News

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
How changes to Covid-19 vaccine policy in the US may affect you
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
FDA approves Moderna's new lower-dose COVID-19 vaccine
Moderna’s newest lower-dose COVID-19 vaccine is approved for all adults 65 and older, and for people aged 12 to 64 who are at ...
News 91d
What to know about Moderna’s new ‘mNexspike’ COVID-19 vaccine
From eligibility to dosage and future rollout, here’s what you need to know about the FDA’s latest vaccine approval.
Marjorie Taylor Greene slams FDA green lighting of mNEXSPIKE COVID-19 vaccine: 'Not MAHA at all!!!'
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
McKnight's Long-Term Care News1d
New COVID-19 vaccine for older adults gets FDA nod as fresh variant emerges
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
Medical News Today4d
Changes to COVID-19 vaccine guidelines: 4 key questions answered
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
US Researchers Develop New mRNA Vaccine To Fight Covid-19
A team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 and H5N1.